Known for their stable structural and thermal properties, diamondoids and their radical cations are viable candidates as carriers for diffuse interstellar bands. 1 While previous diamondoid research has mainly focused on neutral molecules and their derivatives, little is known about their radical cations, which may form in interstellar environments by ionizing radiation. 2 We report the first experimental optical spectrum of the simplest diamondoid cation, the adamantane radical cation (C 10 H 16 + ), obtained via electronic photodissociation spectroscopy at 5 K between 310-1000 nm. The optical spectrum reveals a broad peak between 420-850 nm, assigned to the D 2 ( 2 E) ← D 0 ( 2 A 1 ) transition. This feature exhibits no vibrational structure, despite an experimental temperature below 20 K, due to lifetime broadening and/or Franck-Condon congestion. A second band system originating at 345 nm does reveal a vibrational progression and is attributed to the overlapping D 5 ( 2 A 1 )/D 6 ( 2 E) ← D 0 ( 2 A 1 ) transitions split by the Jahn-Teller effect. Comparison of the spectrum with known diffuse interstellar bands suggests that C 10 H 16 + is not likely to be a carrier. However, the strong absorption features in the UV to near IR show promise in the investigation of higher order diamondoid cations as potential candidates. 3
The
implementation of the hydroformylation reaction for the conversion
of long-chain alkenes into aldehydes still remains challenging on
an industrial scale. One possible approach to overcoming this challenge
is to apply tunable systems employing surfactants. Therefore, a novel
process concept for the hydroformylation of long-chain alkenes to
aldehydes in microemulsions is being investigated and developed at
Technische Universität Berlin, Germany. To test the applicability
of this concept for the hydroformylation in microemulsions on a larger
scale, a miniplant has been constructed and operated. This contribution
presents the proof of concept for hydroformylation in microemulsions
carried out during a 200 h miniplant operation. Throughout the operation
a stable aldehyde yield of 21% and a catalyst loss in the product
phase below 0.1 ppm were achieved, which confirms previous lab scale
findings. Additionally, solution strategies for a stable continuous
operation to overcome challenges such as foaming, phase separation
issues, and coalescence dynamics are discussed herein.
We investigate aqueous multiphase
systems for catalytic gas/liquid
reactions, namely, the rhodium-catalyzed hydroformylation of the long-chain
olefin 1-dodecene. The multiphase system was formulated from 1-dodecene,
water, and a nonionic surfactant, which increases the solubility between
the two nonmiscible liquid phases. On the basis of these systems,
we present in this paper a transfer of lab experiments (semibatch)
to a successful operation of a miniplant in continuous mode. Under
optimized conditions, the reaction showed turnover frequencies of
∼200 h–1 and high selectivity of 98:2 to
the desired linear aldehyde. The miniplant was operated continuously
for a total of 130 h. The control of the phase separation and catalyst
recycling for product isolation for a long time period appeared to
be challenging. Nevertheless, the separation was kept stable for over
24 h. The organic components in the product phase amounted to desired
values between 95 and 99 wt %. The desired 99.99% of the catalyst
remained in the aqueous catalyst phase.
Cryogenic ion spectroscopy of metal–lumiflavin (M+LF) complexes at the level of vibrational resolution illustrates the large impact of alkali ions on the optical properties of this prototypical flavin molecule.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.